Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031078 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jasmin Linh On und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225 Düsseldor…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Triple Negative Breast Neoplasms, Apoptosis, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anton Betz Foundation of the Rheinische Post, German Cancer Aid, German Cancer Foundation.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) represents the most aggressive breast carcinoma subtype lacking efficient therapeutic options. A promising approach in cancer treatment is the pharmacological inhibition of murine double minute 2 (MDM2)-p53 interaction inducing apoptosis in p53 wild-type tumors. However, the role of MDM2 in TNBC with primarily mutant p53 is not well understood. We here selected the clinical-stage MDM2 inhibitors Idasanutlin and Milademetan and investigated their anti-tumoral effects in TNBC. When we analyzed anti-tumor activity in the TNBC cell lines MDA-MB-231, MDA-MB-436, and MDA-MB-468, cellular viability was efficiently reduced, with half maximal inhibitory concentration (IC50) values ranging between 2.00 and 7.62 µM being up to 11-fold lower compared to the well-characterized non-clinical-stage MDM2 inhibitor Nutlin-3a. Furthermore, caspase-3/7 activity was efficiently induced. Importantly, the IC50 values for MDM2 inhibition were equally observed in HCT116 p53+/+ or HCT116 p53−/− cells. Finally, the IC50 was significantly higher in non-malignant MCF-10A cells than in TNBC cells. Taken together, Idasanutlin and Milademetan show a potent anti-tumor activity in TNBC cell culture models by efficiently inducing tumor cell death via apoptosis. This effect was observed despite an inactivating p53 mutation and was apparently independent of p53 expression. Our data suggest that MDM2 is a promising target in TNBC and clinical-stage MDM2 inhibitors should be further evaluated for their potential therapeutic application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.
- Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Kerpener Str. 62, 50937 Cologne, Germany.
- Institute of Pharmaceutical and Medicinal Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225 Düsseldorf, Germany.
- Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.
ORCID-Profile: Jasmin Linh On, Sahel Ghaderi, Greta Hoffmann, Sanil Bhatia, Hans Neubauer, Thomas Kurz
Förderung
- Anton Betz Foundation of the Rheinische Post
- German Cancer Aid
- German Cancer Foundation
- Anton Betz Foundation
Zitieren
APA
On, J. L., Ghaderi, S., Rittmann, C., Hoffmann, G., Gier, F., Woloschin, V., Tu, J. W., Bhatia, S., Kulik, A., Niederacher, D., Neubauer, H., Kurz, T., Fehm, T., & Esser, K. (2025). Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031078
Vancouver
On JL, Ghaderi S, Rittmann C, Hoffmann G, Gier F, Woloschin V, et al. Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031078
BibTeX
@article{On2025,
author = {On, Jasmin Linh and Ghaderi, Sahel and Rittmann, Carina and Hoffmann, Greta and Gier, Franziska and Woloschin, Vitalij and Tu, Jia-Wey and Bhatia, Sanil and Kulik, Andrea and Niederacher, Dieter and Neubauer, Hans and Kurz, Thomas and Fehm, Tanja and Esser, Knud},
title = {Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031078}
}
EUVIMED